| |
| Xpention
Genetics, Inc. is
a biotechnology company that was formed to develop both immunological
and molecular tests for cancer detection in animals and humans
as well as therapeutic vaccines and other treatment methods
for both veterinary and human cancers. Xpention through its
subsidiary has licensed, exclusive rights to a specific genetic
marker called the p65 that has highly specific correlation
to numerous cancers. |
| |
|
 |
| |
| Public
Relations |
| |
| Due to the
recent acquisition of our company, this section is being reworked.
We are trading on the Over the Counter Bulletin Board under the
stock symbol XPNG. To obtain a stock quote and recent news please
follow this link http://finance.yahoo.com/q?s=xpng.ob.
We are very sorry for the inconvenience. |
|
